The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.
 
Manon De Vries
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca
 
Zineb Hamilou
No Relationships to Disclose
 
Sunita Ghosh
No Relationships to Disclose
 
Daniel Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Lori Wood
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Naveen Basappa
Stock and Other Ownership Interests - illumiSonics
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Eisai; Ipsen; Janssen; Merck; Pfizer; Seagen; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer; Seagen
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Johnson & Johnson/Janssen; Pfizer
 
Christian Kollmannsberger
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; Merck; Merck KGaA; Pfizer; Seagen
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen; Merck; Merck KGaA; Pfizer; Seagen
Travel, Accommodations, Expenses - AAA Canada; Ipsen; Janssen Oncology; Pfizer
 
Jeffrey Graham
Honoraria - Ipsen; Janssen Oncology; Merck; Pfizer
Consulting or Advisory Role - AstraZeneca; EMD Serono; ipsen; Janssen Oncology; Merck
 
Bimal Bhindi
Honoraria - Bayer; Merck
Consulting or Advisory Role - Bayer; Ferring; Janssen; Verity Pharmaceuticals
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Medtronic
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Merck; Tersera
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Tersera
 
Georg Bjarnason
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Pfizer
Research Funding - Merck (Inst); Pfizer (Inst)
 
Dominick Bosse
Employment - Need
Honoraria - Amgen; AstraZeneca; Bayer; BMS; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca Canada; Bayer; Bristol-Myers Squibb; Ipsen; Knight Therapeutics; Merck; Pfizer
Research Funding - Ipsen
Travel, Accommodations, Expenses - EMD Serono; ipsen; Janssen; Knight Therapeutics
 
Frederic Pouliot
Stock and Other Ownership Interests - Allogene Therapeutics
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Novartis; Tersera; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Tersera; Tolmar
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Merck (Inst); Novartis; Tersera (Inst)
Patents, Royalties, Other Intellectual Property - Transcriptional system and uses therof for single cell detection
 
Vincent Castonguay
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS; Eisai; GlaxoSmithKline Canada; Ipsen; Janssen; Merck; Pfizer
Research Funding - AstraZeneca Canada (Inst); Bayer (Inst); Bristol-Myers Squibb/Celgene (Inst); Merck (Inst); Pfizer (Inst)
 
Rodney Breau
No Relationships to Disclose
 
Ramy Saleh
No Relationships to Disclose
 
Eric Winquist
Consulting or Advisory Role - Bayer; Eisai; EMD Serono; Ipsen; Merck; Roche
Research Funding - Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Aly-Khan Lalani
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - BioCanRx (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ipsen (Inst); Novartis (Inst); Roche (Inst)
 
Denis Soulieres
Honoraria - Adlai Nortye; AstraZeneca; BIcara Therapeutics; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer
Consulting or Advisory Role - Adlai Nortye; Eisai; Ipsen; Merck; Pfizer
Research Funding - Adlai Nortye (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)